Evidence map›Paper›PMID 26225242›Full record

ArticleCPT: pharmacometrics & systems pharmacology2015

PhIN: A Protein Pharmacology Interaction Network Database.

Z Wang, J Li, R Dang, L Liang, J Lin

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Plant-derived natural products for drug discovery: current approaches and prospects.The Nucleus : an international journal of cytology and allied topics · 2022
    Review
  2. Review
  3. Article
  4. YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery.Computational and structural biotechnology journal · 2018
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Z WangState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University Tianjin, China.
J LiState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University Tianjin, China ; High-Throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biomedicine and Technology Tianjin, China.
R DangState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University Tianjin, China.
L LiangState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University Tianjin, China ; High-Throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biomedicine and Technology Tianjin, China.
J LinState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University Tianjin, China ; High-Throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biomedicine and Technology Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Network pharmacology is a new and hot concept in drug discovery for its ability to investigate the complexity of polypharmacology, and becomes more and more important in drug development. Here we report a protein pharmacology interaction network database (PhIN), aiming to assist multitarget drug discovery by providing comprehensive and flexible network pharmacology analysis. Overall, PhIN contains 1,126,060 target-target interaction pairs in terms of shared compounds and 3,428,020 pairs in terms of shared scaffolds, which involve 12,419,700 activity data, 9,414 targets, 314 viral targets, 652 pathways, 1,359,400 compounds, and 309,556 scaffolds. Using PhIN, users can obtain interacting target networks within or across human pathways, between human and virus, by defining the number of shared compounds or scaffolds under an activity cutoff. We expect PhIN to be a useful tool for multitarget drug development. PhIN is freely available at http://cadd.pharmacy.nankai.edu.cn/phin/.

Identifiers

PMID26225242
PMCPMC4394615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.